← Back
SAN GIOVANNI
December, 06th | 17:45 - 18:45
WET AMD TREATMENT 1
Add to calendar
Chairs: HO ALLEN, LANZETTA PAOLO, KOROBELNIK JEAN-FRANÇOIS
December, 06th | 17:45 - 17:49
Retinal fluid dynamics and visual outcomes in neovascular AMD: A large longitudinal study across early and later treatment phases in two tertiary settings
ZUR DINAH
Add to calendar
Retinal fluid dynamics and visual outcomes in neovascular AMD: A large longitudinal study across early and later treatment phases in two tertiary settings
ZUR DINAH
Add to calendar
December, 06th | 17:49 - 17:53
Exploring Macular Atrophy in Neovascular AMD: Focusing on Type 3 Macular Neovascularization
BORRELLI ENRICO
Add to calendar
Exploring Macular Atrophy in Neovascular AMD: Focusing on Type 3 Macular Neovascularization
BORRELLI ENRICO
Add to calendar
December, 06th | 17:53 - 17:57
The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France
SOLER VINCENT
Add to calendar
The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France
SOLER VINCENT
Add to calendar
December, 06th | 17:57 - 18:01
Faricimab Efficacy in Type 1 Macular Neovascularization
EANDI CHIARA
Add to calendar
Faricimab Efficacy in Type 1 Macular Neovascularization
EANDI CHIARA
Add to calendar
December, 06th | 18:01 - 18:05
Comparing Real-World Outcomes: Faricimab Post-bevacizumab (2nd Line) vs. Post-aflibercept/ranibizumab (3rd Line) in Exudative Diseases Treatment
LOEWENSTEIN ANAT
Add to calendar
Comparing Real-World Outcomes: Faricimab Post-bevacizumab (2nd Line) vs. Post-aflibercept/ranibizumab (3rd Line) in Exudative Diseases Treatment
LOEWENSTEIN ANAT
Add to calendar
December, 06th | 18:05 - 18:09
Real world experience with faricimab and aflibercept 8mg
KITCHENS JOHN
Add to calendar
Real world experience with faricimab and aflibercept 8mg
KITCHENS JOHN
Add to calendar
December, 06th | 18:09 - 18:13
Faricimab in neovascular AMD complicated by pigment epithelium detachment: an AI-assisted evaluation of early morphological changes
SARAO VALENTINA
Add to calendar
Faricimab in neovascular AMD complicated by pigment epithelium detachment: an AI-assisted evaluation of early morphological changes
SARAO VALENTINA
Add to calendar
December, 06th | 18:13 - 18:17
Population pharmacokinetic modeling and simulation of ocular clearance for aflibercept 8 mg and 2 mg and association with durability of effect
VERITTI DANIELE
Add to calendar
Population pharmacokinetic modeling and simulation of ocular clearance for aflibercept 8 mg and 2 mg and association with durability of effect
VERITTI DANIELE
Add to calendar
December, 06th | 18:17 - 18:21
SwitchAI Study: Use of RetinSight Artificial Intelligence software for monitoring wAMD patients switched from anti-VEGF to faricimab, primary results from three french centers
ERGINAY ALI
Add to calendar
SwitchAI Study: Use of RetinSight Artificial Intelligence software for monitoring wAMD patients switched from anti-VEGF to faricimab, primary results from three french centers
ERGINAY ALI
Add to calendar
December, 06th | 18:21 - 18:25
Comparative analysis of short-term lesion-drying efficacy in exudative AMD
VIOLA FRANCESCO
Add to calendar
Comparative analysis of short-term lesion-drying efficacy in exudative AMD
VIOLA FRANCESCO
Add to calendar